SANTHERA PHARM.HD.SF 0,10
SANTHERA PHARM.HD.SF 0,10/ CH1276028821 /
SANN
- -
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
-EUR
|
-
|
0 Turnover: 0.00 |
-Bid Size: - |
-Ask Size: - |
123.3 mill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
4.34 CHF |
- |
EPS Diluted: |
- CHF |
- |
Revenues per Share: |
8.19 CHF |
725.59% |
Book Value per Share: |
4.79 CHF |
- |
Cash Flow per Share: |
3.77 CHF |
- |
Dividend per Share: |
- CHF |
- |
Total |
in mill. |
|
Revenues: |
103.38 CHF |
1,283.33% |
Net Income: |
54.78 CHF |
- |
Operating Cash Flow: |
47.62 CHF |
- |
Cash and Cash Equivalents: |
30.37 CHF |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
2.11 |
2.26 |
P/S Ratio: |
1.12 |
1.20 |
P/BV ratio: |
1.91 |
2.05 |
P/CF Ratio: |
2.42 |
2.60 |
PEG: |
- |
- |
Earnings Yield: |
47.43% |
44.24% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
123.3 mill. EUR |
133.31 mill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
- EUR |
- EUR |
Shares Outstanding: |
12.62 mill. |
|
Profitability
Gross Profit Margin: |
96.87% |
EBIT Margin: |
66.56% |
Net Profit Margin: |
52.99% |
Return on Equity: |
90.60% |
Return on Assets: |
49.97% |
Financial Strength
Liquidity I / Cash Ratio: |
69.35% |
Liquidity II / Quick Ratio: |
74.27% |
Liquidity III / Current Ratio: |
79.14% |
Debt / Equity Ratio: |
81.31% |
Dynam. Debt / Equity Ratio: |
103.24% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- CHF |
Revenues / Employee: |
- CHF |
Net Income / Employee: |
- CHF |
Total Assets / Employee: |
- CHF |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
IFRS |